Cornell Pochily Investment Advisors, Inc. Amgen Inc Transaction History

Cornell Pochily Investment Advisors, Inc.

$301 Million
Q2 2025

A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 7,610 shares of AMGN stock, worth $2.27 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

7,610

Previous 7,641 0.41%

Holding current value

$2.27 Million

Previous $2.38 Million 10.76%

% of portfolio

0.71%

Previous 0.85%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	SELL	$262.28 - $309.85 $8,130 - $9,605	-31 Reduced 0.41%	7,610 $2.12 Million
Q1 2025 Apr 17, 2025	SELL	$258.59 - $327.36 $11,119 - $14,076	-43 Reduced 0.56%	7,641 $2.38 Million
Q4 2024 Jan 22, 2025	SELL	$258.78 - $328.31 $21,996 - $27,906	-85 Reduced 1.09%	7,684 $2 Million
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $13,922 - $15,182	-45 Reduced 0.58%	7,769 $2.5 Million
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $9,196 - $11,175	-35 Reduced 0.45%	7,814 $2.44 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $53,505 - $64,587	199 Added 2.6%	7,849 $2.23 Million
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $6,648 - $7,499	26 Added 0.34%	7,650 $2.2 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $6,340 - $7,872	-29 Reduced 0.38%	7,624 $2.05 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $5,356 - $6,334	25 Added 0.33%	7,653 $1.7 Million
Q1 2023 Apr 17, 2023	SELL	$225.79 - $275.2 $5,418 - $6,604	-24 Reduced 0.31%	7,628 $1.84 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $89,779 - $114,075	-392 Reduced 4.87%	7,652 $2.01 Million
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.01%	8,044 $1.81 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $22,840 - $25,417	-99 Reduced 1.22%	8,043 $1.96 Million
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $7,235 - $8,004	-33 Reduced 0.4%	8,142 $1.97 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $472,538 - $540,777	-2,376 Reduced 22.52%	8,175 $1.84 Million
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $56,463 - $66,154	-266 Reduced 2.46%	10,551 $2.24 Million
Q2 2021 Jul 23, 2021	SELL	$233.58 - $259.14 $40,409 - $44,831	-173 Reduced 1.57%	10,817 $2.64 Million
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $1,553 - $1,810	-7 Reduced 0.06%	10,990 $2.74 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $649 - $773	3 Added 0.03%	10,997 $2.53 Million
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $49,745 - $55,321	212 Added 1.97%	10,994 $2.79 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $76,750 - $94,183	388 Added 3.73%	10,782 $2.54 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $21,139 - $28,037	116 Added 1.13%	10,394 $2.11 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $9,649 - $12,403	51 Added 0.5%	10,278 $2.48 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $12,535 - $15,020	-72 Reduced 0.7%	10,227 $1.98 Million
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $15,503 - $18,173	93 Added 0.91%	10,299 $1.9 Million
Q1 2019 Apr 19, 2019	BUY	$180.87 - $203.88 $95,318 - $107,444	527 Added 5.44%	10,206 $1.94 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $84,204 - $98,294	472 Added 5.13%	9,679 $1.88 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $47,063 - $53,058	254 Added 2.84%	9,207 $1.91 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $12,121 - $13,615	73 Added 0.82%	8,953 $1.65 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $121,989 - $142,560	720 Added 8.82%	8,880 $1.51 Million
Q4 2017 Apr 05, 2018	BUY	$168.79 - $188.59 $1.38 Million - $1.54 Million	8,160	8,160 $1.42 Million

Others Institutions Holding AMGN

# of Institutions

3,276

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.

Account

Cornell Pochily Investment Advisors, Inc. Amgen Inc Transaction History